CRISPR Therapeutics AG (CRSP) Return on Sales Growth (1y) (2017 - 2026)
CRISPR Therapeutics AG (CRSP) Return on Sales Growth (1y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROS Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
0.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
5.00 |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
0.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
CRISPR Therapeutics AG |
5.21 Bn |
2.76 Bn |
- |
73.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
73.00 |
| Dec 31, 2025 |
545.00 |
| Sep 30, 2025 |
23.00 |
| Jun 30, 2025 |
11.00 |
| Mar 31, 2025 |
74.00 |
| Dec 31, 2024 |
10.00 |
| Sep 30, 2024 |
-141.00 |
| Jun 30, 2024 |
-243.00 |
| Mar 31, 2024 |
-231.00 |
| Dec 31, 2023 |
18,421.00 |
| Sep 30, 2023 |
1,855.00 |
| Jun 30, 2023 |
1,175.00 |
| Mar 31, 2023 |
190.00 |
| Dec 31, 2022 |
-18,410.00 |
| Sep 30, 2022 |
-1,702.00 |
| Jun 30, 2022 |
-1,177.00 |
| Mar 31, 2022 |
19.00 |
| Dec 31, 2021 |
278.00 |
| Sep 30, 2021 |
470.00 |
| Jun 30, 2021 |
1,812.00 |
